ClinicalTrials.gov and the World Health Organization portal were also reviewed for ongoing or unpublished studies
While Lilly continues to dominate headlines with its GIP/GLP-1 treatments, Novo Nordisk has been playing the long game, quietly iterating and expanding on its GLP-1 platform
Thats significant, as in the U.S., weight management is an industry worth more than $190 billiona number that speaks to the perpetual challenge that weight loss presents
Keeping a symptom diary documenting the timing, severity, and characteristics of joint symptoms can provide valuable information for clinical decision-making
First, its helpful to understand what semaglutide is and how it works inside your body
doi:10.1016/S0140-6736(21)01324-6Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes